Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy - PubMed
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the end of April, 2020, over 3...
pubmed.ncbi.nlm.nih.gov
